In early 2004, The International Lyme and Associated Diseases Society (ILADS) released the first evidence-based comprehensive set of Lyme Disease Treatment Guidelines to assist physicians, public health officials and organizations involved in the evaluation and treatment of Lyme disease. The Lyme Disease Association (national) and the California Lyme Disease Association endorsed the Guidelines which were then peer-reviewed and made available to professionals and to the public.
Lyme is the number one tick-borne illness in the US. The CDC reports there are 24,000 new cases of Lyme disease in the US but the CDC says that figure could be under reported by tenfold. ILADS believes newly diagnosed cases of Lyme may occur at a rate five times higher than the number of new AIDS cases. Chronic Lyme is reported in up to half of patients treated for Lyme.
A short summary of ILADS treatment recommendations includes:
- Treatment for symptomatic presentations
- Treatment should not be withheld based on laboratory testing
- Early use of antibiotics is imperative
- Longer courses of antibiotics treatment may be needed
- Repeat antibiotics for recurrence
For a more in-depth understanding go to:
Taken from the website: ILADS-Lyme Treatment Guidelines